PM-M05_04: Monitoring the comorbidities
- Comorbidity Register
- NTEP Performance Indicator - Percentage of TB Notified Patients with Known HIV Status
- RCA for low performance of Percentage of TB Notified Patients with known HIV Status
- Reporting of ICF activities among PLHIV
- Monitoring of indicators related to TB-HIV
- Monitoring of indicators related to TB-HIV Treatment
- Monitoring of indicators related to TB-HIV prevention
- TB-HIV joint review mechanisms
- Performance Indicators and Targets for TB-HIV Collaborative Activities
- Quarterly report on TB-HIV Collaborative Activities
- Ni-kshay HIV Status Report
PM-M04_05: Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Pre-treatment Evaluation [PTE]
- Eligibility Criteria for the Use of Bedaquiline [Bdq] in MDR/RR-TB Treatment
- Shorter oral Bedaquiline-containing MDR/RR-TB regimen
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Eligibility Criteria
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Drug Dose Administration
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Dosage of Drugs for Adults
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Replacement Sequence of Drugs
- Follow up sputum examination for Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen
PM-M04_06: Longer Oral M/XDR-TB Regimen
- Pre-treatment Evaluation [PTE] in Longer Oral M/XDR-TB Regimen
- Eligibility Criteria for Longer Oral M/XDR-TB Regimen
- Longer Oral M/XDR-TB: Regimen and Duration
- Treatment Extension in Longer Oral M/XDR-TB Regimen
- Dosages of M/XDR-TB Drugs for Adult in Longer Oral M/XDR-TB Regimen
- Details of Replacement Sequence of Drugs in Longer Oral M/XDR-TB Regimen
- Follow up sputum examination for Longer Oral M/XDR-TB DR-TB Regimen
PM-M04_04: Isoniazid [H] Mono/Poly DR-TB Regimen
- Isoniazid [H] Mono/Poly DR-TB Regimen: Pre-treatment Evaluation
- Eligibility Criteria for H Mono/poly DR-TB Regimen
- Regimen, Duration and Dosage for Isoniazid [H] Mono/Poly DR-TB Regimen
- Replacement Sequence in the H Mono/Poly DR-TB
- Follow up sputum examination for Isoniazid [H] Mono/Poly DR-TB Regimen